We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+24.56%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+548.24%
AUM
$467B
AUM Growth
+$83.7B
Cap. Flow
+$2.63B
Cap. Flow %
0.56%
Top 10 Hldgs %
22.59%
Holding
4,219
New
118
Increased
2,550
Reduced
1,055
Closed
119

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$524M
2
META icon
Meta Platforms (Facebook)
META
+$458M
3
OTIS icon
Otis Worldwide
OTIS
+$345M
4
TMUS icon
T-Mobile US
TMUS
+$307M
5
ABBV icon
AbbVie
ABBV
+$280M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$878M
2
RTN
Raytheon Company
RTN
+$537M
3
BMY icon
Bristol-Myers Squibb
BMY
+$435M
4
AAPL icon
Apple
AAPL
+$389M
5
ACN icon
Accenture
ACN
+$216M

Sector Composition

Rank Sector Weight
1 Technology 23.72%
2 Healthcare 14.52%
3 Financials 12.98%
4 Consumer Discretionary 10.98%
5 Communication Services 9.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NFINW
4051
DELISTED
Netfin Acquisition Corp. Warrants
NFINW
$18K ﹤0.01%
12,559
-36,700
-75% -$16.9K
TIO
4052
DELISTED
Tingo Group, Inc. Common Stock
TIO
$17K ﹤0.01%
11,589
AWX icon
4053
Avalon Holdings
AWX
$9.96M
$16K ﹤0.01%
10,368
ENVB icon
4054
Enveric Biosciences
ENVB
$6.32M
0
ENSV
4055
DELISTED
Enservco Corp.
ENSV
$16K ﹤0.01%
6,552
JSPRW icon
4056
Japer Therapeutics Warrants
JSPRW
$15K ﹤0.01%
16,750
-103,000
-86% -$64.1K
FRTX
4057
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$15K ﹤0.01%
355
ACHV icon
4058
Achieve Life Sciences
ACHV
$659M
$14K ﹤0.01%
1,807
ATHE
4059
Alterity Therapeutics
ATHE
$81.5M
$14K ﹤0.01%
1,213
CHNR icon
4060
China Natural Resources
CHNR
$4.55M
$14K ﹤0.01%
303
BRN icon
4061
Barnwell Industries
BRN
$14.8M
$12K ﹤0.01%
14,145
ZOM
4062
DELISTED
Zomedica Corp.
ZOM
$12K ﹤0.01%
+51,640
New +$9.84K
GGE
4063
DELISTED
Green Giant Inc. Common Stock
GGE
$11K ﹤0.01%
6,970
GDYNW
4064
DELISTED
Grid Dynamics Holdings, Inc. Warrant
GDYNW
$11K ﹤0.01%
10,000
LODE icon
4065
Comstock
LODE
$208M
$10K ﹤0.01%
1,123
TAOP icon
4066
Taoping
TAOP
$6.63M
$10K ﹤0.01%
12
IEAWW
4067
DELISTED
Infrastructure and Energy Alternatives, Inc. Warrant
IEAWW
$10K ﹤0.01%
73,267
SSY
4068
DELISTED
SunLink Health Systems
SSY
$9K ﹤0.01%
10,217
TOVX icon
4069
Theriva Biologics
TOVX
$9.64M
$9K ﹤0.01%
71
HIND
4070
Vyome Holdings
HIND
$14.8M
0
AEHL icon
4071
Antelope Enterprise Holdings
AEHL
$8.63M
$7K ﹤0.01%
2
INDP icon
4072
Indaptus Therapeutics
INDP
$172M
$7K ﹤0.01%
12
HUSN
4073
DELISTED
Hudson Capital Inc. Ordinary Shares
HUSN
$7K ﹤0.01%
5,274
ADNWW
4074
DELISTED
Advent Technologies Holdings Warrant
ADNWW
$6K ﹤0.01%
12,346
-39,102
-76% -$12.7K
AVGR
4075
DELISTED
Avinger, Inc. Common Stock
AVGR
$6K ﹤0.01%
74

Similar funds

Geode Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Geode Capital Management held 4,219 positions worth $467B, up 22% from $384B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Geode Capital Management's Q2 2020 filing shows 118 new, 2,550 increased, 1,055 reduced and 119 closed positions. Its largest new stake was Otis Worldwide: 6,650,358 shares worth $377M. The largest sale was Allergan plc, an estimated $878M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • Geode Capital Management's largest Q2 2020 buy was Otis Worldwide: 6,650,358 shares worth $377M.
  • Geode Capital Management added most to Amazon in Q2 2020, an estimated $524M increase.
  • Geode Capital Management's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $435M.
  • Geode Capital Management fully exited Allergan plc in Q2 2020, selling an estimated $878M.
  • Geode Capital Management's ten largest holdings make up 23% of its $467B portfolio in Q2 2020.
  • Geode Capital Management opened 118 new positions and closed 119 in Q2 2020.
  • Geode Capital Management's portfolio value rose 22% quarter-over-quarter to $467B.

Based on Geode Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.